Supportive care protocols
Supportive care protocols are those studies that do not directly treat a patient's main (transplanted) disease. They instead look at related issues like complications of transplantation, infection control, graft-versus-host disease (GVHD) treatment, and individual variation in pharmacokinetics (a drug's actions on the body over a period of time). These studies include:
This investigator-driven
protocol studies the use of extracorporeal
photopheresis (ECP) as a treatment for patients with steroid-refractory acute GVHD.
This study involves patients at a number of different hospitals. The study tracks children and adults with GVHD to see how their symptoms change over time and how to best track these changes in symptoms.
This investigator-driven study is open at a number of sites, and has the goal of creating a new, more accurate way to measure symptoms of GHVD.
This investigator-driven study provides mesenchymal
stem cells (Prochymal) to patients with steroid-refractory acute GVHD.
This industry-sponsored study provides Defibrotide as a treatment for patients with veno-occlusive disease (VOD) with multi-organ failure.
This multi-site protocol studies the use of Etanercept for the treatment of idiopathic
pneumonia syndrome occurring after
allogeneic stem cell transplantation. Etanercept is given along with
corticosteroids.